MedTrace Logo

Blood Transfusion Applications in Hip Replacements

NCT05627544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2023-03-10

No results posted yet for this study

Summary

Introduction and Aim In the intraoperative or postoperative period of hip replacement surgeries, approximately 46% of patients receive erythrocyte transfusion. 'Patient blood management' protocols have been established in order to reduce the frequency of perioperative surgical bleeding and transfusion. The aim of this study is to evaluate the patients who underwent hip replacement by the same experienced surgeon; to evaluate retrospectively in terms of patient characteristics, surgical and anesthesia management, blood transfusion frequency.

Methods The characteristics of patients who underwent hip replacement (total hip replacement, revision hip replacement, partial hip replacement) operation by the same experienced surgeon between 2010-2022 at Baskent University after the approval of Baskent University Medical and Health Sciences Research Board, results will be analyzed retrospectively through perioperative follow-up forms and review of patient files.

Expectations and scientific contributions Preparing patients for surgery, determining the causes of blood loss during and after surgery and creating preventive strategies are important for all operations, especially hip replacement surgeries. While determining the strategies, the main aim should be to see the pre-, intra- and post-operative period as a whole, to determine the transfusion risks according to the comorbidities and anemia of the patients, and to determine the anesthesia and analgesia managements that reduce blood loss in the intraoperative and postoperative periods.

Conditions

  • Blood Transfusion
  • Hip Replacement
  • Anesthesia Management

Interventions

PROCEDURE

Anesthesia management/Hip replacement surgery

The effect of anesthesia management on blood transfusion practices in hip replacement surgeries

PROCEDURE

Demographic data

The effect of demographic data on blood transfusion practices in hip replacement surgeries

PROCEDURE

Chronic diseases

The effect of chronic diseases on blood transfusion practices in hip replacement surgeries

PROCEDURE

Postoperative complication

The effect of blood transfusion applications on postoperative complications in hip replacement surgeries

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Principal Investigators

  • Yonca Özvardar Pekcan · Baskent University

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2022-11-01
Completion
2022-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05627544 on ClinicalTrials.gov